Local view for "http://purl.org/linkedpolitics/eu/plenary/2012-10-23-Speech-2-523-750"

Predicate	Value (sorted: default)
rdf:type	lpv_eu:Speech2
dcterms:Date	"2012-10-23"^^xsd:date2
dcterms:Is Part Of	lp_eu:Explanations of vote2
dcterms:Language	"pt"^^xsd:language2
lpv:document identification number	"en.20121023.45.2-523-750"2
lpv:hasSubsequent	lp_eu:2012-10-23-Speech-2-524-0002
lpv:speaker	lp:João Ferreira2
lpv:spokenAs	member; Delegation to the EU-Former Yugoslav Republic of Macedonia Joint Parliamentary Committee (2009-09-16--2013-02-03)3 unknown; Partido Comunista Português (2009-07-14--2014-06-30)3 substitute; Delegation for relations with the countries of the Andean Community (2009-09-16--2014-06-30)3 vice-chair; EUL/NGL (2012-02-07--2014-06-30)3 member; PECH (2012-01-19--2014-06-30)3 member; Delegation to the ACP-EU Joint Parliamentary Assembly (2009-09-16--2014-06-30)3 substitute; ENVI (2012-01-19--2014-06-30)3 substitute; BUDG (2012-01-19--2014-06-30)3
lpv:translated text	"This report approves the mobilisation of the EGF in the amount of EUR 4 325 854 in order to support the reintegration in the labour market of 987 workers made redundant by AstraZeneca in Sweden, in the pharmaceutical sector, due to ‘structural changes in world trade patterns due to globalisation’ – always the same line ... – outsourcing and cuts made in R&D investment at European level. Unlike the Asian communities which, during the recession, have increased their investment in R&D, Europe, which is fixated with tackling the deficits, is restricting public support for R&D, an approach that could last for years, with inevitable consequences on employment rates and medical research. Each new mobilisation of this Fund can only merit our strongest condemnation and denunciation. This is the result of the policies imposed by the EU on Europe. We need to find another approach."@en1

Named graphs describing this resource:

The resource appears as object in 2 triples

Context graph